tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI

Karyopharm Therapeutics (KPTI) Balance Sheet

1,073 Followers

Karyopharm Therapeutics Balance Sheet

Karyopharm Therapeutics's total assets for Q4 2023 were $240.44M, a decrease of -10.94% from the previous quarter. KPTI total liabilities were $376.64M for the fiscal quarter, a 1.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 240.44M$ 358.17M$ 305.31M$ 313.05M$ 294.96M
Total Liabilities
$ 376.64M$ 374.83M$ 384.98M$ 262.50M$ 245.19M
Total Equity Gross Minority
$ -149.17M$ 27.28M$ -79.67M$ 50.55M$ 49.77M
Total Capitalization
$ 208.42M$ 153.45M$ 89.62M$ 168.47M$ 159.63M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 13.20M$ 14.85M
Currency in USD

Karyopharm Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis